Browse by author
Lookup NU author(s): Dr Paul Smith,
Professor Robert Lightowlers
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Pathogenic mutations of the mitochondrial genome are frequently found to co-exist with wild-type mtDNA molecules, a state known as heteroplasmy. In most disease cases, the mutation is recessive with manifestation of a clinical phenotype occurring when the proportion of mutated mtDNA exceeds a high threshold. The concept of increasing the ratio of healthy to mutated mtDNA as a means to correcting the biochemical defect has received much attention. A number of strategies are highlighted in this article, including manipulation of the mitochondrial genome by antigenomic drugs or restriction endonucleases, zinc finger peptide-targeted nucleases and exercise-induced gene shifting. The feasibility of these approaches has been demonstrated in a number of models, however more work is necessary before use in human patients.
Author(s): Smith PM, Lightowlers RN
Publication type: Article
Publication status: Published
Journal: Journal of Inherited Metabolic Disease
Print publication date: 27/05/2010
ISSN (print): 0141-8955
ISSN (electronic): 1573-2665
Altmetrics provided by Altmetric